刺激响应药物输送系统中的纳米材料有助于精确治疗血液性疾病
Lingrui Li1,2, Wei Jiang3, Shaowei Qiu1,2
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China. qiushaowei@ihcams.ac.cn.
Journal of materials chemistry. B
|June 11, 2025
概括
响应刺激的药物递送系统 (SRDDS) 通过释放药物来响应特定的身体信号,精确地准疾病. 先进的纳米技术和蛋白质组学增强了这些系统的个性化医疗,特别是在固体瘤和血液恶性瘤治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 药理学 药理学 是一个学科.
背景情况:
- 刺激响应药物递送系统 (SRDDS) 调节细胞条件以产生治疗效果.
- 早期的SRDDS专注于使用SOD和CAT等酶的抗炎和抗氧化功能.
- 瘤微环境研究和生物信息学的进步扩大了SRDDS的应用.
研究的目的:
- 探索SRDDS在精密医学中的演变和扩展应用.
- 突出奥米克学研究,特别是蛋白质组学在推进SRDDS方面的作用.
- 讨论纳米技术和蛋白质组学的整合,以改善疾病治疗.
主要方法:
- 药物化学与生物环境和免疫反应的整合.
- 利用瘤微环境研究和生物信息学为SRDDS开发.
- 利用omics数据,特别是蛋白质组,以确定精确的药物标.
主要成果:
- SRDDS已经从基本的功能演变为精密医学的复杂工具.
- 蛋白质组学为新药开发和个性化治疗提供了精确的目标.
- 生物相容纳米材料通过膜蛋白相互作用作为有效的载体,用于通过膜蛋白相互作用进行向药物输送.
结论:
- 纳米技术和蛋白质组学的结合代表了SRDDS的重大进步.
- 在精确治疗各种疾病方面,SRDDS提供了实质性的实用价值.
- 这些综合系统对于个性化医疗至关重要,特别是在瘤学中.
相关概念视频
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


